The Promises of CRISPR Genome Editing in Biomedicine
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
The prevalence of neurological diseases has increased rapidly, and they are now the second biggest…
As next-generation gene-editing technologies become increasingly popular, biotech industry stakeholders carry the responsibility to ensure…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The controversial decision by the European courts in 2018 to regulate gene-edited organisms as GMOs…
The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing…
CRISPR-Cas9 has taken the world by storm with the promise of making gene editing much…
CRISPR has been all over the news in the past couple of years, and with…
Update (14/01/20): Horizon Discovery will offer partners access to a precise version of CRISPR gene…
With the year coming to a close, it’s time to review the most important biotech…
Gene therapies are experiencing a new era. CRISPR is current. CRISPR is trendy. CRISPR is…
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…